Federal Register Notice: FDA is correcting a notice in the 2/11 Federal Register that announced the withdrawal of approval of 103 NDAs and 35 ANDAs. The document published with an error in the identification of the ANDA from ANDA 75-108 to ANDA 76-108 for amiodarone hydrochloride injection, 50 mg/ mL, held by Hospira, Inc. To view this notice, click here.
